Iron deficiency in Russia: main problems and possible solutions

DOI

https://dx.doi.org/10.18565/aig.2021.11.237-244

Stuklov N.I., Basiladze I.G., Kisly N.D.
1) Peoples’ Friendship University of Russia (RUDN University), Ministry of Science and Higher Education of the Russian Federation, Moscow, Russia; 2) National Medical Research Radiological Center, Ministry of Health of the Russian Federation, Moscow, Russia; 3) A.S. Loginov Moscow Clinical Scientific Center, Moscow Health Department, Moscow, Russia

The paper reviews the current epidemiological problems of iron deficiency and anemia in Russia. The authors place emphasis on women of reproductive age and pregnant women who represent the most socially significant group of the population. Morbidity rates and population characteristics of the problem are presented in detail. The paper examines the significance of global medical and social issues and the consequences of iron deficiency, issues related to the quality of life, clinical manifestations, the impact on reproductive function and the consequences of pregnancy. The authors give a detailed description of the modern understanding of iron metabolism, its regulation, mechanisms of absorption and transportation, and possible schemes for the development of iron deficiency. The authors explain the role of such iron regulatory proteins as divalent metallotransporter, ferroportin, hepcidin and their interaction, the values of other metals involved in iron metabolism, such as copper and manganese. The pathogenetic aspects of sideropenic and anemic syndromes, their significance in reproductive function and fetal formation are considered in detail. Both classical and novel algorithms and approaches are given. The paper presents modern algorithms for the treatment of latent iron deficiency and iron deficiency anemia, possible approaches and recommendations of various medical specialists. This paper attempts to show the most effective medications and approaches to their use in women with iron deficiency anemia. The advantages of liquid medications are described; the most effective doses, regimens, and duration of their use are discussed. As a result, the authors summarize all the information, present the simplest schemes for the diagnosis and treatment of different stages of iron deficiency and suggest a new approach to the treatment of iron deficiency, using the previous solution of the problem.
Conclusion: Iron deficiency remains a serious problem in Russia. However, there is a possibility that incidence of iron deficiency will be reduced in our country in the near future.

iron deficiency

iron deficiency anemia

iron gluconate

anemia treatment

prevention of iron deficiency

women of reproductive age

risk groups

Full text (in Russian)

World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: WHO; 2002. 236p.
WHO/NHD/01.3. World Health Organization. Iron deficiency anaemia. Assessment, prevention, and control. A guide for programme managers. Geneva: WHO; 2001. 132p.
Резолюция совета экспертов по железодефицитной анемии у женщин. Акушерство и гинекология. Новости. Мнения. Обучение. 2020; 8(4): 28-36. [Expert council resolution of the on iron-deficiency anemia in women. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie/Obstetrics and Gynecology: News, Opinions, Training. 2020; 8(4): 28-36. (in Russian)]. https://dx.doi.org/10.24411/2303-9698-2020-14004.
Beard J.L. Iron requirements in adolescent females. J. Nutr. 2000; 130(2S Suppl.): 440S-2S. https://dx.doi.org/10.1093/jn/130.2.440S.
WHO. Food and Agriculture Organization of the United Nation. Human vitamin and mineral requirements. Report of a joint FAO/WHO expert consultation, Bangkok, Thailand. Food and Nutrition Division FAO Rome; 2001. 303p.
Fairweather-Tait S. Iron requirements and prevalence of iron deficiency in adolescents. An overview. In: Hallberg L., Asp N.G., eds. Iron nutrition in heath and disease. John Libbey and Co. Ltd.; 1996: 137-48.
Abbaspour N., Hurrell R., Kelishadi R. Review on iron and its importance for human health. J. Res. Med. Sci. 2014; 19(2): 164-74.
Демихов В.Г., Морщакова Е.Ф., Румянцев А.Г. Патогенез и лечение анемии беременных. М.: Практическая медицина; 2015. 224с. [Demikhov V.G., Morshchakova E.F., Rumyantsev A.G. Pathogenesis and treatment of anemia in pregnant women. M.: Practical medicine; 2015. 224 p. (in Russian)].
Стуклов Н.И., Козинец Г.И., Тюрина Н.Г. Учебник по гематологии. М.: Практическая медицина; 2018. 336с. [Stuklov N.I., Kozinets G.I., Tyurina N.G. Hematology Tutorial. M.: Practical medicine; 2018. 336 p. (in Russian)].
Стуклов Н.И. Железодефицитная анемия в практике гинеколога. Алгоритмы диагностики, профилактики и лечения. Акушерство и гинекология. 2016; 7: 99-104. [Stuklov N.I. Iron-deficiency anemia in gynecological practice: Algorithms for diagnosis, prevention, and treatment. Obstetrics and Gynecology. 2016; 7: 99-104. (in Russian)]. http://dx.doi.org/10.18565/aig.2016.7.99-104.
Шилов А.М. Хроническая сердечная недостаточность и железодефицитная анемия в практике врача первичного звена здравоохранения. Лечебное дело. 2013; 3: 8-16. [Shilov A.M. Chronic Heart Failure and Iron-Deficiency Anemia in General Practice. Lechebnoe delo Journal. 2013; 3: 8-16. (in Russian)].
Стуклов Н.И. Дефицит железа и анемия у больных хронической сердечной недостаточностью. Рациональная фармакотерапия в кардиологии. 2017; 13(5): 651-60. [Stuklov N.I. Iron Deficiency and Anemia in Patients with Chronic Heart Failure. Rational Pharmacotherapy in Cardiology. 2017; 13(5): 651-60. (in Russian)]. https://dx.doi.org/10.20996/1819-6446-2017-13-5-651-660.
Дикке Г.Б., Стуклов Н.И. Латентный дефицит железа и железодефицитная анемия у беременных. Алгоритмы диагностики и лечения. Фарматека. 2021; 28(6): 19-24. [Dikke G.B., Stuklov N.I. Latent iron deficiency and iron deficiency anemia in pregnant women. Diagnostic and treatment algorithms. Farmateka. 2021; 28(6): 19-24. (in Russian)]. https://dx.doi.org/10.18565/pharmateca.2021.6.00-00.
Means R.T. Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients. 2020; 12(2): 447. https://dx.doi.org/10.3390/nu12020447.
Blot I., Diallo D., Tchernia G. Iron deficiency in pregnancy: effects of the newborn. Curr. Opin. Hematol. 1999; 6(2): 65-70. https://dx.doi.org/10.1097/00062752-199903000-00002.
Лебедев В.В., Демихов В.Г., Дмитриев А.В., Аиари М., Фомина М.А. Сравнительная эффективность и безопасность применения препаратов двух- и трехвалентного железа для лечения железодефицитной анемии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2016; 15(4): 5-12. [Lebedev V.V., Demikhov V.G., Dmitriev A.V., Aiari M., Fomina M.A. A comparative efficacy and safety of using ferrous and ferric iron preparations for management of iron-deficiency anaemia. Pediatric Haematology/ Oncology and Immunopathology. 2016; 15(4): 5-12. (in Russian)]. https://dx.doi.org/10.24287/1726-1708-2016-15-4-5-12.
Dallalio G., Law E., Means R.T. Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood. 2006; 107(7):2702-4. https://dx.doi.org/10.1182/blood-2005-07-2854.
Сахин В.Т., Маджанова Е.Р., Крюков Е.В., Казаков С.П., Рукавицын О.А. Анемия хронических заболеваний: особенности патогенеза и возможности терапевтической коррекции (обзор литературы и результаты собственных исследований). Онкогематология. 2018; 13(1): 45-53. [Sakhin V.T., Madzhanova E.R., Kryukov E.V. et al. Anemia of chronic disease: features of pathogenesis and possible therapeutic correction (literature review and results of own research). Oncohematology. 2018;13(1): 45-53. (in Russian)]. https://dx.doi.org/10.17650/1818-8346-2018-13-1-45-53.
Кирилюк А.А. Железосодержащие лекарственные средства: от клинической фармакологии до фармацевтической помощи (Сообщение 1). Вестник фармации. 2020; 3: 81-97. [Kirilyuk A.A. Iron-containing Medicines: from Clinical Pharmacology to Pharmaceutical Assistance (Report 1). Bulletin of Pharmacy. 2020; 3(89): 81-97. (in Russian)].
Jacobs P., Johnson G., Wool L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. J. Med. 1984; 15(5-6): 367-77.
Ребров В.Г., Егорова Е.Ю., Громова О.А., Торшин И.Ю. Парадокс лечения анемий: когда меньшее становится лучшим. Эффективная фармакотерапия. 2010; 3: 26-8. [Rebrov V.G., Egorova E.Yu., Gromova O.A., Torshin I.Yu. The paradox of anemia treatment: when less becomes better. Standards of treatment. 2010; 3: 26-8. (in Russian)].
Семенова Е., Кунина М., Стуклов Н. Роль меди и марганца в метаболизме железа. Врач. 2013; 12: 47-52. [Semenova E., Kunina M., Stuklov N. Role of copper and manganese in iron metabolism. Vrach/Doctor Journal. 2013; 12: 47-52. (in Russian)].
Логутова Л.С. Анемия у беременных: вопросы этиологии, диагностики и лечения. РМЖ. Мать и дитя. 2016; 5: 290-3. [Logutova L.S. Anemia in pregnant women: etiology, diagnosis and treatment. Russian Medical Journal Mother and Child. 2016; 5: 290-3. (in Russian)].
Pizarro F., Yip R., Dallman P.R., Olivares M., Hertrampf E., Walter T. Iron status with different infant regimens: relevance to screening and prevention of iron deficiency. J. Pediatr. 1991; 118(5): 687-92. https://dx.doi.org/10.1016/s0022-3476(05)80027-7.
WHO. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020. 72р.
WHO. Guideline: daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016.
Gillespie S.R., Kevany J., Mason J.B., eds. United Nations. Administrative Committee on Coordination. Subcommittee on Nutrition. Controlling iron deficiency: a report based on an ACC/SCN Workshop. United Nations, Administrative Committee on Coordination/Subcommittee on Nutrition; 1991. 93p.
Стуклов Н.И., Леваков С.А., Сушинская Т.В., Митченкова А.А., Ковальчук М.О. Профилактика и лечение анемии у женщин репродуктивного возраста при гинекологических заболеваниях. Акушерство и гинекология. 2020; 3: 218-26. [Stuklov N.I., Levakov S.A., Sushinskaya T.V., Mitchenkova A.A., Kovalchuk M.O. Prevention and treatment of anemia in reproductive-aged women with gynecological diseases. Obstetrics and Gynecology. 2020; 3: 218-26. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.3.218-226.
Data, WHO. Guideline: intermittent iron and folic acid supplementation in menstruating women. Geneva: World Health Organization; 2011.
DeMaeyer Е.М., Dallman Р., Gurney J.M., Hallberg L., Sood S.K., Srikantia S.G. Preventing and controlling iron deficiency anaemia through primary health care. А guide for health administrators and programme managers. Geneva: World Неаlth Organization; 1989. 61p.
Кунина М.Ю., Семенова Е.Н., Стуклов Н.И. Особенности ответа на терапию железодефицитной анемии препаратом Тотема в зависимости от этиологии. Вестник последипломного медицинского образования. 2014; 1: 74-5. [Kunina M.Yu., Semenova E.N., Stuklov N.I. Features of the response to therapy of iron deficiency anemia with a Totem preparation depending on the etiology. Bulletin of Postgraduate Medical Education. 2014; 1: 74-5. (in Russian)].
Ковригина Е.С., Казанец Е.Г., Карамян Н.А., Айвазова Д.Х., Лукьянова Е.Г., Панфилова Е.Л. Современные методы диагностики железодефицитной анемии у беременных и критерии оценки эффективности ферротерапии. Гинекология. 2005; 7(2): 90-2. [Kovrigina E.S., Kazanets E.G., Karamyan N.A. et al. Modern methods of diagnosis of iron deficiency anemia in pregnant women and criteria for evaluating the effectiveness of ferrotherapy. Gynecology. 2005; 7(2): 90-2. (in Russian)].
Стуклов Н.И. Мета-анализ данных переносимости питьевой формы глюконата железа (II), меди и марганца (препарат Тотема) при лечении железодефицитной анемии у детей и взрослых. Современная педиатрия. 2012; 7: 52-60. [Stuklov N.I. Meta-analysis of data on the tolerability of the drinking form of iron (II) gluconate, copper and manganese (Totem preparation) in the treatment of iron deficiency anemia in children and adults. Journal Zemsky doctor. 2012; 7(47): 52-60. (in Russian)].

Received 21.10.2021

Accepted 17.11.2021

Nikolay I. Stuklov, Dr. Med. Sci., Professor at the Department of Hospital Therapy with Courses of Endocrinology, Hematology and Clinical Laboratory Diagnostics, Medical Institute, Peoples’ Friendship University of Russia (RUDN University), Head of the Course of Hematology; Senior Researcher at the Department of High-Dose Chemotherapy with a Bone Marrow Transplantation Unit, P.A. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiology Center,
stuklovn@gmail.com, 6 Miklukho-Maklay str., Moscow, 117198, Russian Federation.
Irakli G. Basiladze, doctor-hematologist, Department of Hematology, A.S. Loginov Moscow Clinical Scientific and Practical Center, Moscow Health Department,
86 Shosse Entuziastov str., Moscow, 111123, Russian Federation.
Nikolay D. Kisly, Dr. Med. Sci., Professor, Department of Hospital Therapy with Courses of Endocrinology, Hematology and Clinical Laboratory Diagnostics, Medical Institute, Peoples’ Friendship University of Russia (RUDN University), 6 Miklukho-Maklay str., Moscow, 117198, Russian Federation.
Corresponding author: Nikolay I. Stuklov, stuklovn@gmail.com

Authors’ contributions: Stuklov N.I., Basiladze I.G., Kisly N.D. – development of the article concept, review of publications on the topic of the article, writing the text, editing.
Conflicts of interest: The authors declare that they have no competing interests.
Funding: The study was performed with the financial support of Innotech, LLC.
For citation: Stuklov N.I., Basiladze I.G., Kisly N.D.
Iron deficiency in Russia: main problems and possible solutions.
Akusherstvo i Ginekologiya / Obstetrics and Gynecology. 2021; 11: 237-244 (in Russian)
https://dx.doi.org/10.18565/aig.2021.11.237-244

Iron deficiency in Russia: main problems and possible solutions

Stuklov N.I., Basiladze I.G., Kisly N.D.

Keywords

References

About the Authors

Similar Articles